The Molecular Biology (MB) Module has been in effect since the first funding period of the Case VSRC P30 grant in1997, has been stable in personnel, with Dr. Brady-Kalnay as Director, and from 1998 until July, 2006, and Carol Luckeyas Manager. In the last funding period, the Module has worked especially closely with the Specialized Animal ResourceModule to genotype over 45 mouse strains. Taken together with the previous functions of this Module, and with theacquisition of the ABI Prism 7000 qPCR has also become part of this Module (from the Bioinformatics module), weanticipate that the Module will be very heavily utilized. . .The MB Module will be located in centralized VSRC facilities in the Institute of Pathology, in close proximity to thevision investigators in the School (Appendix D). The equipment is listed in form HH, and is located as shown in theadjacent diagram. The Module Manager designed the space to maximize efficient use of the major equipment, includingthe thermocycler and qPCR. The MB Module is responsible forproviding skilled technical expertise, equipment and techniques forPCR analysis/genotyping, quantification and imaging of gels,cloning, generating bacterial strains and the central storage ofbacteria, vectors and cDNA constructs.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Center Core Grants (P30)
Project #
2P30EY011373-11
Application #
7286546
Study Section
Special Emphasis Panel (ZEY1-VSN (03))
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-04-30
Support Year
11
Fiscal Year
2007
Total Cost
$98,750
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Hughes, Taylor E T; Pumroy, Ruth A; Yazici, Aysenur Torun et al. (2018) Structural insights on TRPV5 gating by endogenous modulators. Nat Commun 9:4198
Gulati, Sahil; Jin, Hui; Masuho, Ikuo et al. (2018) Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor. Nat Commun 9:1996
Senapati, Subhadip; Gragg, Megan; Samuels, Ivy S et al. (2018) Effect of dietary docosahexaenoic acid on rhodopsin content and packing in photoreceptor cell membranes. Biochim Biophys Acta Biomembr 1860:1403-1413
Cheng, Yan; Du, Yunpeng; Liu, Haitao et al. (2018) Photobiomodulation Inhibits Long-term Structural and Functional Lesions of Diabetic Retinopathy. Diabetes 67:291-298
Flückiger, Rudolf; Cocuzzi, Enzo; Nagaraj, Ram H et al. (2018) DAF in diabetic patients is subject to glycation/inactivation at its active site residues. Mol Immunol 93:246-252
Lam, Morrie; Mast, Natalia; Pikuleva, Irina A (2018) Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo. Mol Pharmacol 93:101-108
Gragg, Megan; Park, Paul S-H (2018) Misfolded rhodopsin mutants display variable aggregation properties. Biochim Biophys Acta Mol Basis Dis 1864:2938-2948
Parmar, Vipul M; Parmar, Tanu; Arai, Eisuke et al. (2018) A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res 27:95-104
Cheng, Yu-Shiuan; Linetsky, Mikhail; Gu, Xilin et al. (2018) Light-induced generation and toxicity of docosahexaenoate-derived oxidation products in retinal pigmented epithelial cells. Exp Eye Res :
Palczewska, Grazyna; Stremplewski, Patrycjusz; Suh, Susie et al. (2018) Two-photon imaging of the mammalian retina with ultrafast pulsing laser. JCI Insight 3:

Showing the most recent 10 out of 510 publications